1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Leukemia Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Gleevec
        1.2.3 Sprycel
        1.2.4 Tasigna
        1.2.5 Clolar
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Leukemia Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Leukemia Therapeutics Market Perspective (2017-2028)
    2.2 Leukemia Therapeutics Growth Trends by Region
        2.2.1 Leukemia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Leukemia Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Leukemia Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Leukemia Therapeutics Market Dynamics
        2.3.1 Leukemia Therapeutics Industry Trends
        2.3.2 Leukemia Therapeutics Market Drivers
        2.3.3 Leukemia Therapeutics Market Challenges
        2.3.4 Leukemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Leukemia Therapeutics Players by Revenue
        3.1.1 Global Top Leukemia Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Leukemia Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Leukemia Therapeutics Revenue
    3.4 Global Leukemia Therapeutics Market Concentration Ratio
        3.4.1 Global Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Leukemia Therapeutics Revenue in 2021
    3.5 Leukemia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Leukemia Therapeutics Product Solution and Service
    3.7 Date of Enter into Leukemia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Therapeutics Breakdown Data by Type
    4.1 Global Leukemia Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Leukemia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Leukemia Therapeutics Breakdown Data by Application
    5.1 Global Leukemia Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Leukemia Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Leukemia Therapeutics Market Size (2017-2028)
    6.2 North America Leukemia Therapeutics Market Size by Country (2017-2022)
    6.3 North America Leukemia Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Leukemia Therapeutics Market Size (2017-2028)
    7.2 Europe Leukemia Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Leukemia Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Leukemia Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Leukemia Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Leukemia Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Leukemia Therapeutics Market Size (2017-2028)
    9.2 Latin America Leukemia Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Leukemia Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Leukemia Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Leukemia Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Leukemia Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Leukemia Therapeutics Introduction
        11.1.4 Roche Revenue in Leukemia Therapeutics Business (2017-2022)
        11.1.5 Roche Recent Development
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Company Detail
        11.2.2 GlaxoSmithKline Business Overview
        11.2.3 GlaxoSmithKline Leukemia Therapeutics Introduction
        11.2.4 GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2017-2022)
        11.2.5 GlaxoSmithKline Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Leukemia Therapeutics Introduction
        11.3.4 Novartis Revenue in Leukemia Therapeutics Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Detail
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb Leukemia Therapeutics Introduction
        11.4.4 Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Recent Development
    11.5 Eisai
        11.5.1 Eisai Company Detail
        11.5.2 Eisai Business Overview
        11.5.3 Eisai Leukemia Therapeutics Introduction
        11.5.4 Eisai Revenue in Leukemia Therapeutics Business (2017-2022)
        11.5.5 Eisai Recent Development
    11.6 Biogen Idec
        11.6.1 Biogen Idec Company Detail
        11.6.2 Biogen Idec Business Overview
        11.6.3 Biogen Idec Leukemia Therapeutics Introduction
        11.6.4 Biogen Idec Revenue in Leukemia Therapeutics Business (2017-2022)
        11.6.5 Biogen Idec Recent Development
    11.7 ERYtech Pharma
        11.7.1 ERYtech Pharma Company Detail
        11.7.2 ERYtech Pharma Business Overview
        11.7.3 ERYtech Pharma Leukemia Therapeutics Introduction
        11.7.4 ERYtech Pharma Revenue in Leukemia Therapeutics Business (2017-2022)
        11.7.5 ERYtech Pharma Recent Development
    11.8 Celgene
        11.8.1 Celgene Company Detail
        11.8.2 Celgene Business Overview
        11.8.3 Celgene Leukemia Therapeutics Introduction
        11.8.4 Celgene Revenue in Leukemia Therapeutics Business (2017-2022)
        11.8.5 Celgene Recent Development
    11.9 Genmab
        11.9.1 Genmab Company Detail
        11.9.2 Genmab Business Overview
        11.9.3 Genmab Leukemia Therapeutics Introduction
        11.9.4 Genmab Revenue in Leukemia Therapeutics Business (2017-2022)
        11.9.5 Genmab Recent Development
    11.10 Cephalon
        11.10.1 Cephalon Company Detail
        11.10.2 Cephalon Business Overview
        11.10.3 Cephalon Leukemia Therapeutics Introduction
        11.10.4 Cephalon Revenue in Leukemia Therapeutics Business (2017-2022)
        11.10.5 Cephalon Recent Development
    11.11 Clavis Pharma
        11.11.1 Clavis Pharma Company Detail
        11.11.2 Clavis Pharma Business Overview
        11.11.3 Clavis Pharma Leukemia Therapeutics Introduction
        11.11.4 Clavis Pharma Revenue in Leukemia Therapeutics Business (2017-2022)
        11.11.5 Clavis Pharma Recent Development
    11.12 Pfizer
        11.12.1 Pfizer Company Detail
        11.12.2 Pfizer Business Overview
        11.12.3 Pfizer Leukemia Therapeutics Introduction
        11.12.4 Pfizer Revenue in Leukemia Therapeutics Business (2017-2022)
        11.12.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Gleevec
    Table 3. Key Players of Sprycel
    Table 4. Key Players of Tasigna
    Table 5. Key Players of Clolar
    Table 6. Key Players of Others
    Table 7. Global Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Leukemia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Leukemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Leukemia Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Leukemia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Leukemia Therapeutics Market Share by Region (2023-2028)
    Table 13. Leukemia Therapeutics Market Trends
    Table 14. Leukemia Therapeutics Market Drivers
    Table 15. Leukemia Therapeutics Market Challenges
    Table 16. Leukemia Therapeutics Market Restraints
    Table 17. Global Leukemia Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Leukemia Therapeutics Market Share by Players (2017-2022)
    Table 19. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutics as of 2021)
    Table 20. Ranking of Global Top Leukemia Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Leukemia Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Leukemia Therapeutics Product Solution and Service
    Table 24. Date of Enter into Leukemia Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Leukemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Leukemia Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Leukemia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Leukemia Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Leukemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Leukemia Therapeutics Revenue Market Share by Application (2017-2022)
    Table 32. Global Leukemia Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Leukemia Therapeutics Revenue Market Share by Application (2023-2028)
    Table 34. North America Leukemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Leukemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Leukemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Leukemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Leukemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Leukemia Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Leukemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Leukemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Leukemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Leukemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Roche Company Detail
    Table 45. Roche Business Overview
    Table 46. Roche Leukemia Therapeutics Product
    Table 47. Roche Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 48. Roche Recent Development
    Table 49. GlaxoSmithKline Company Detail
    Table 50. GlaxoSmithKline Business Overview
    Table 51. GlaxoSmithKline Leukemia Therapeutics Product
    Table 52. GlaxoSmithKline Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 53. GlaxoSmithKline Recent Development
    Table 54. Novartis Company Detail
    Table 55. Novartis Business Overview
    Table 56. Novartis Leukemia Therapeutics Product
    Table 57. Novartis Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 58. Novartis Recent Development
    Table 59. Bristol-Myers Squibb Company Detail
    Table 60. Bristol-Myers Squibb Business Overview
    Table 61. Bristol-Myers Squibb Leukemia Therapeutics Product
    Table 62. Bristol-Myers Squibb Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 63. Bristol-Myers Squibb Recent Development
    Table 64. Eisai Company Detail
    Table 65. Eisai Business Overview
    Table 66. Eisai Leukemia Therapeutics Product
    Table 67. Eisai Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 68. Eisai Recent Development
    Table 69. Biogen Idec Company Detail
    Table 70. Biogen Idec Business Overview
    Table 71. Biogen Idec Leukemia Therapeutics Product
    Table 72. Biogen Idec Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 73. Biogen Idec Recent Development
    Table 74. ERYtech Pharma Company Detail
    Table 75. ERYtech Pharma Business Overview
    Table 76. ERYtech Pharma Leukemia Therapeutics Product
    Table 77. ERYtech Pharma Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 78. ERYtech Pharma Recent Development
    Table 79. Celgene Company Detail
    Table 80. Celgene Business Overview
    Table 81. Celgene Leukemia Therapeutics Product
    Table 82. Celgene Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 83. Celgene Recent Development
    Table 84. Genmab Company Detail
    Table 85. Genmab Business Overview
    Table 86. Genmab Leukemia Therapeutics Product
    Table 87. Genmab Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 88. Genmab Recent Development
    Table 89. Cephalon Company Detail
    Table 90. Cephalon Business Overview
    Table 91. Cephalon Leukemia Therapeutics Product
    Table 92. Cephalon Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 93. Cephalon Recent Development
    Table 94. Clavis Pharma Company Detail
    Table 95. Clavis Pharma Business Overview
    Table 96. Clavis Pharma Leukemia TherapeuticsProduct
    Table 97. Clavis Pharma Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 98. Clavis Pharma Recent Development
    Table 99. Pfizer Company Detail
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Leukemia TherapeuticsProduct
    Table 102. Pfizer Revenue in Leukemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 103. Pfizer Recent Development
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Leukemia Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Gleevec Features
    Figure 3. Sprycel Features
    Figure 4. Tasigna Features
    Figure 5. Clolar Features
    Figure 6. Others Features
    Figure 7. Global Leukemia Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Leukemia Therapeutics Report Years Considered
    Figure 11. Global Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Leukemia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Leukemia Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Leukemia Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Leukemia Therapeutics Revenue in 2021
    Figure 17. North America Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Leukemia Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Leukemia Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Leukemia Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Leukemia Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Leukemia Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Leukemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Roche Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 46. GlaxoSmithKline Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 49. Eisai Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 50. Biogen Idec Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 51. ERYtech Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 52. Celgene Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 53. Genmab Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 54. Cephalon Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 55. Clavis Pharma Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Leukemia Therapeutics Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed